HRP20070057T3 - 2-substituted pyrimidines - Google Patents

2-substituted pyrimidines

Info

Publication number
HRP20070057T3
HRP20070057T3 HR20070057T HRP20070057T HRP20070057T3 HR P20070057 T3 HRP20070057 T3 HR P20070057T3 HR 20070057 T HR20070057 T HR 20070057T HR P20070057 T HRP20070057 T HR P20070057T HR P20070057 T3 HRP20070057 T3 HR P20070057T3
Authority
HR
Croatia
Prior art keywords
alkyl
cyano
cycloalkyl
alkenyl
alkoxy
Prior art date
Application number
HR20070057T
Other languages
English (en)
Croatian (hr)
Inventor
Schw�gler Anja
Gewehr Markus
Mller Bernd
Grote Thomas
Grammenos Wassilios
Tormo I Blasco Jordi
Gypser Andreas
Rheinheimer Joachim
Blettner Carsten
Sch�fer Peter
Schieweck Frank
Wagner Oliver
Stierl Reinhard
Sch�fl Ulrich
Strathmann Siegfired
Scherer Maria
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of HRP20070057T3 publication Critical patent/HRP20070057T3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20070057T 2003-07-24 2007-02-14 2-substituted pyrimidines HRP20070057T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10333857 2003-07-24
DE10357714 2003-12-09
PCT/EP2004/007877 WO2005012261A1 (de) 2003-07-24 2004-07-15 2-substituierte pyrimidine

Publications (1)

Publication Number Publication Date
HRP20070057T3 true HRP20070057T3 (en) 2007-07-31

Family

ID=34117367

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20070057T HRP20070057T3 (en) 2003-07-24 2007-02-14 2-substituted pyrimidines

Country Status (30)

Country Link
US (1) US7375108B2 (xx)
EP (1) EP1651618B1 (xx)
JP (1) JP2006528603A (xx)
KR (1) KR20060052857A (xx)
AP (1) AP2157A (xx)
AR (1) AR045100A1 (xx)
AT (1) ATE350370T1 (xx)
AU (1) AU2004261373B8 (xx)
BR (1) BRPI0412891A (xx)
CA (1) CA2532718A1 (xx)
CO (1) CO5660292A2 (xx)
CR (1) CR8184A (xx)
CY (1) CY1106391T1 (xx)
DE (1) DE502004002570D1 (xx)
DK (1) DK1651618T3 (xx)
EA (1) EA010566B1 (xx)
EC (1) ECSP066278A (xx)
ES (1) ES2279395T3 (xx)
HR (1) HRP20070057T3 (xx)
IL (1) IL172848A0 (xx)
MA (1) MA27949A1 (xx)
MX (1) MXPA06000038A (xx)
NZ (1) NZ545103A (xx)
PE (1) PE20050882A1 (xx)
PL (1) PL1651618T3 (xx)
PT (1) PT1651618E (xx)
SI (1) SI1651618T1 (xx)
TW (1) TW200516075A (xx)
UY (1) UY28436A1 (xx)
WO (1) WO2005012261A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080132522A1 (en) * 2004-07-14 2008-06-05 Basf Aktiengesellschaft 2-Substituted Pyrimidines, Method for Their Production and Their Use for Controlling Pathogenic Fungi
CL2007002231A1 (es) * 2006-08-02 2008-04-11 Basf Ag Uso de compuestos derivados de 5-(het) arilpirimidina para combatir hongos daninos; compuestos derivados de 5-(het) arilpirimidina; agente fungicida; y agente farmaceutico.
PT2640709T (pt) * 2010-11-16 2016-07-13 Acetylon Pharmaceuticals Inc Compostos de pirimidina hidroxiamida como inibidores de proteína desacetilase e métodos de utilização dos mesmos
EP3054952B1 (en) 2013-10-08 2022-10-26 Acetylon Pharmaceuticals, Inc. Combinations of histone deacetylase 6 inhibitors and the her2 inhibitor lapatinib for use in the treatment of breast cancer
US9278963B2 (en) 2013-10-10 2016-03-08 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
EP3060217B1 (en) 2013-10-24 2022-06-08 Mayo Foundation for Medical Education and Research Treatment of polycystic diseases with an hdac6 inhibitor
CA2932411A1 (en) 2013-12-03 2015-06-11 Acetylon Pharmaceuticals, Inc. Combinations of histone deacetylase inhibitors and immunomodulatory drugs
US9464073B2 (en) 2014-02-26 2016-10-11 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
EP3166603B1 (en) 2014-07-07 2020-02-12 Acetylon Pharmaceuticals, Inc. Treatment of leukemia with histone deacetylase inhibitors
CA2969790A1 (en) 2014-12-05 2016-06-09 University of Modena and Reggio Emilia Combinations of histone deacetylase inhibitors and bendamustine
US10272084B2 (en) 2015-06-01 2019-04-30 Regenacy Pharmaceuticals, Llc Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
JP2019515909A (ja) 2016-04-19 2019-06-13 アセチロン ファーマシューティカルズ インコーポレイテッドAcetylon Pharmaceuticals,Inc. 慢性リンパ性白血病の治療を目的とするhdac阻害剤単独またはbtk阻害剤との配合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU778913B2 (en) 2000-06-13 2004-12-23 Basf Aktiengesellschaft Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
JP4361736B2 (ja) * 2001-03-15 2009-11-11 ビーエーエスエフ ソシエタス・ヨーロピア 5−フェニルピリミジン、その製造方法、製造のための中間体および有害な菌類を防除するための使用
CN1312134C (zh) 2001-11-19 2007-04-25 巴斯福股份公司 5-苯基嘧啶化合物、包含它们的组合物、其制备方法及其用途

Also Published As

Publication number Publication date
NZ545103A (en) 2008-06-30
US20070105873A1 (en) 2007-05-10
MXPA06000038A (es) 2006-03-21
PL1651618T3 (pl) 2007-05-31
ATE350370T1 (de) 2007-01-15
AP2006003497A0 (en) 2006-02-28
UY28436A1 (es) 2005-02-28
CR8184A (es) 2006-10-06
PT1651618E (pt) 2007-03-30
TW200516075A (en) 2005-05-16
JP2006528603A (ja) 2006-12-21
AU2004261373B8 (en) 2010-11-04
SI1651618T1 (sl) 2007-06-30
EP1651618A1 (de) 2006-05-03
CO5660292A2 (es) 2006-07-31
IL172848A0 (en) 2006-06-11
KR20060052857A (ko) 2006-05-19
ECSP066278A (es) 2006-07-28
PE20050882A1 (es) 2005-12-01
CA2532718A1 (en) 2005-02-10
EP1651618B1 (de) 2007-01-03
US7375108B2 (en) 2008-05-20
CY1106391T1 (el) 2011-10-12
ES2279395T3 (es) 2007-08-16
AU2004261373A1 (en) 2005-02-10
MA27949A1 (fr) 2006-06-01
AR045100A1 (es) 2005-10-12
WO2005012261A1 (de) 2005-02-10
BRPI0412891A (pt) 2006-10-03
DK1651618T3 (da) 2007-05-14
EA200600212A1 (ru) 2006-08-25
AP2157A (en) 2010-09-13
DE502004002570D1 (de) 2007-02-15
AU2004261373B2 (en) 2010-08-19
EA010566B1 (ru) 2008-10-30

Similar Documents

Publication Publication Date Title
HRP20070057T3 (en) 2-substituted pyrimidines
RS51888B (en) N- (PHENYL (PIPERIDIN-2-IL) METHYL) BENZAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY
RS51224B (sr) Jedinjenja piperazina sa herbicidnim delovanjem
NZ590887A (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
TW200604175A (en) Ortho substituted aryl or heteroaryl amide compounds
EA200601847A1 (ru) Замещённые метиларил- или гетероариламидные соединения
RS54638B1 (en) HCV SERIN PROTEASE INHIBITORS DERIVED FROM MACROCYCLIC PROLINE
NO20065830L (no) Substituerte 2-kinolyloksazoler som er anvendbare som PDE4-inhibitorer.
WO2005092858A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
RS53108B (en) AMINO-1,3,5-TRIAZINES N-REPLACED BY CHIRAL BICYCLIC RADICALS, THE PROCESS FOR THEIR PREPARATION, THEIR COMPOUNDS AND THEIR APPLICATIONS AS HERBICIDES AND PLANT GROWTH REGULATORS
NZ601967A (en) Pde10 inhibitors and related compositions and methods
RS53569B1 (en) NEW COMPOUNDS AND COMPOSITIONS, AND PROCEDURES FOR USE
HUP0402310A2 (hu) 1,6-Naftiridin-származékok mint antidiabetikumok és ezeket tartalmazó gyógyszerkészítmények
MXPA05010874A (es) Compuestos n-heterociclicos condensados y su uso como antagonistas del receptor del factor liberador de corticotropina.
TW200610760A (en) 2-(pyridin-2-yl)pyrimidines and their use for controlling harmful fungi
JOP20190239A1 (ar) مركبات مثبطة لـ vmat2 وتركيبات منها
MX2010005283A (es) Compuestos de piridilmetil-sulfonamida.
RS51190B (sr) Aminoacilni derivati kao prolekovi i lekovi za lečenje tromboembolijskih bolesti
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
HK1081194A1 (en) 6-amino-1h-indazole compounds as phosphodiesterase4 inhibitors, pharmaceutical compositions compris ing the same, and use thereof
ES2139246T3 (es) Derivados de n-(benciloxi sustituido en orto)imina y su uso como fungicidas, acaricidas o insecticidas.
EA201390374A1 (ru) Гетероциклические соединения для лечения или профилактики расстройств, вызываемых ослабленной нейротрансмиссией серотонина, норэпинефрина или допамина
RS53965B1 (en) ACILBENZENA DERIVATIVES
TW200700419A (en) 5,6-dialkyl-7-aminoazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds
HRP20030797B1 (en) Fungicide compositions